Another Look At Marketing Vs. R&D In Pharma
FiercePharma has some good figures to back up my posts the other day on R&D spending versus marketing. I mentioned how many people, when they argue that drug companies spend more on marketing than they do on research, are taking the entire SG&A …
See all stories on this topic »
Network Marketing System: Tired Of Half-Truths? – Ken Acree
You've heard that a Network Marketing system is critical for your success. Are you In summary ready for all the facts about what YOU need to do? Find out…
See all stories on this topic »
Marketing Specialist Joins SCS Global Services' Environmental Certification …
EMERYVILLE, Calif., May 23, 2013 — /PRNewswire/ — SCS Global Services (SCS), a third party verifier of environmental and sustainability certification, is pleased to announce the expansion of its marketing team. Julie Gengo, a veteran marketing and …
See all stories on this topic »
Popular Questions
What does another look at marketing versus R&D in pharma reveal about their different goals?
Marketing in pharma focuses on communicating a medicine’s value, reaching appropriate audiences, and supporting adoption within regulatory limits. R&D focuses on discovering, testing, and improving treatments before they reach the market. Comparing the two shows that commercial success depends on both scientific development and effective, compliant communication.
How should companies balance marketing and R&D in pharma when allocating resources?
Companies should fund R&D according to scientific opportunity, clinical evidence, development risk, and patient need. Marketing resources should reflect the product’s approved uses, competitive environment, launch timing, and communication requirements. Cross-functional planning can connect research milestones with realistic market expectations without allowing promotional goals to influence scientific conclusions.
Why is compliance important when taking another look at marketing versus R&D in pharma?
Pharmaceutical marketing must accurately represent approved indications, benefits, risks, and supporting evidence. R&D teams must follow research protocols, data-integrity standards, and applicable clinical regulations. Keeping these responsibilities distinct reduces the risk of misleading claims, protects patients, and preserves confidence in the development process.
How can marketing and R&D teams work together more effectively in pharma?
R&D can share validated evidence, development timelines, and limitations with marketing through structured cross-functional reviews. Marketing can contribute information about patient needs, healthcare-provider questions, and market access requirements without directing scientific outcomes. Regular documentation and clear approval processes help both groups coordinate while maintaining independent scientific and promotional oversight.